Position in PRGO
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$256,352
New position
Shares Held
24,673
first reported quarter
Ownership
0.018%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#171
of 334 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bleakley Financial Group, LLC holds $14,352,616 across 10 Drug Manufacturers - Specialty & Generic names. PRGO ranks #10 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
432,956 | $6,940,284 | |
| 2 | LQDA |
Liquidia Corp
|
22,739 | $1,812,980 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
14,600 | $1,619,724 | |
| 4 | ZTS |
Zoetis Inc.
|
14,835 | $1,066,043 | |
| 5 | HROW |
Harrow, Inc.
|
24,067 | $1,022,125 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
11,272 | $532,827 | |
| 7 | AQST |
Aquestive Therapeutics, Inc.
|
112,314 | $467,226 | |
| 8 | HLN |
Haleon plc
|
40,539 | $378,228 |
All Filings in PRGO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $256,352 | 24,673 | Shares | Sole | 2026-08-05 | |
| No filing history on record for this holder in this stock. | ||||||